A Systematic Review of Reported Outcomes in ADPKD Studies

Sara S. Jdiaa(University of Toronto), Nedaa Husainat(St. Mary's Hospital), Razan Mansour(University of Kansas Medical Center), Mohamad A. Kalot(University at Buffalo, State University of New York), Kerri McGreal(University of Kansas Medical Center), Fouad T. Chebib(Mayo Clinic), Ronald D. Perrone(Tufts Medical Center), Alan S.L. Yu(University of Kansas Medical Center), Reem A. Mustafa(University of Kansas Medical Center)
Kidney International Reports
July 5, 2022
Cited by 8Open Access
Full Text

Abstract

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a progressive genetic kidney disease. Studies of ADPKD presented results using different outcome measures. We aimed to summarize outcomes reported in ADPKD studies, including composite outcomes. Methods: We conducted a systematic review of published studies that included patients with ADPKD and measured kidney-related outcomes. We searched published databases and included all studies regardless of design with at least 100 participants for observational studies. We excluded studies that were limited to dialysis, transplant, or pregnancy outcomes in patients with ADPKD. Results: analyses, and 94 observational studies). We identified 214 different outcomes, and we categorized them into the 24 main outcome domains. In addition, the review identified 13 articles that reported 9 different composite outcomes. Conclusion: The finding highlights the inconsistency in the outcomes reported by researchers and how they are measured in ADPKD studies. The variability in the outcomes reported supports the need to standardize outcomes in ADPKD studies.


Related Papers

No related papers found

Powered by citation graph analysis